Home » Values clash » Wild & New Stuff » Long-term Data Show Ra-223 Safe in Advanced Prostate Cancer – Medscape

Long-term Data Show Ra-223 Safe in Advanced Prostate Cancer – Medscape

See on Scoop.itProstate Cancer: Psycho-Social Aspects to Disease Pathway Management

Long-term Data Show Ra-223 Safe in Advanced Prostate Cancer Medscape In an updated report of the ALSYMPCA trial, no major safety issues were identified within ~1.5 years after the end of treatment in a population of men with castration-resistant…

Terry Hill‘s insight:

This is good news!

See on login.medscape.com

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: